Lung Cancer
Conditions
Interventions
Photodynamic therapy
Sponsors
Nippon Medical School Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Cancer nodule within 20mm in maximum measured by thin-slice CT Negative for lymphnode or distant metastasis measured by FDG-PET, abdomnal CT or US, Brain CT or MRI. ECOG PS 0-2 Over 20 years old Platete: 100000~400000 PT-INR: less than 1.4 Diagnosed as non-small cell lung cancer by trans-bronchal biopsy or cytology Inoperable case or Reject operation cases with written informed concent
Exclusion criteria
Exclusion criteria: Patients with anti-coagulant dose, except for salicylic acid formulation in the past week women who are/may pregnant, or lactating Patients with serious complications such as heart disease, liver disease and kidney failure Patients who have the porphyria Patients who have the sunlight hypersensitivity Maximum diameter of solid part adenocarcinoma of more than 50% of the nodule diameter Patients who have been determined to be inappropriate as a subject upon the doctor's discretion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| frequency of adverse event of grade 2 or more within 180 days of PDT | — |
Countries
Japan
Contacts
Public ContactUsuda Jutsuo
Nippon Medical School Hospital Respiratory Surgery
Outcome results
None listed